Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


Articles published in J Neurol Neurosurg Psychiatry

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    April 2018
  1. HUMPHRIES MD, Obeso JA, Dreyer JK
    Insights into Parkinson's disease from computational models of the basal ganglia.
    J Neurol Neurosurg Psychiatry. 2018 Apr 17. pii: jnnp-2017-315922.
    PubMed     Text format     Abstract available


    March 2018
  2. WISSEL BD, Dwivedi AK, Merola A, Chin D, et al
    Functional neurological disorders in Parkinson disease.
    J Neurol Neurosurg Psychiatry. 2018 Mar 16. pii: jnnp-2017-317378.
    PubMed     Text format     Abstract available


  3. HALLETT M
    Patients with Parkinson disease are prone to functional neurological disorders.
    J Neurol Neurosurg Psychiatry. 2018 Mar 16. pii: jnnp-2017-317684.
    PubMed     Text format    


  4. RADDER DLM, Nonnekes J, Bloem BR
    Intensive inpatient rehabilitation for persons with Parkinson's disease: last resort or pre-emptive strike?
    J Neurol Neurosurg Psychiatry. 2018 Mar 13. pii: jnnp-2017-317812.
    PubMed     Text format    


    February 2018
  5. ABBES M, Lhommee E, Thobois S, Klinger H, et al
    Subthalamic stimulation and neuropsychiatric symptoms in Parkinson's disease: results from a long-term follow-up cohort study.
    J Neurol Neurosurg Psychiatry. 2018 Feb 7. pii: jnnp-2017-316373.
    PubMed     Text format     Abstract available


    January 2018
  6. BLOMSTEDT P, Stenmark Persson R, Hariz GM, Linder J, et al
    Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluation.
    J Neurol Neurosurg Psychiatry. 2018 Jan 31. pii: jnnp-2017-317219.
    PubMed     Text format     Abstract available


  7. MALEK N, Weil RS, Bresner C, Lawton MA, et al
    Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study.
    J Neurol Neurosurg Psychiatry. 2018 Jan 29. pii: jnnp-2017-317348.
    PubMed     Text format     Abstract available


  8. BOT M, Schuurman PR, Odekerken VJJ, Verhagen R, et al
    Deep brain stimulation for Parkinson's disease: defining the optimal location within the subthalamic nucleus.
    J Neurol Neurosurg Psychiatry. 2018 Jan 20. pii: jnnp-2017-316907.
    PubMed     Text format     Abstract available


  9. FERRAZZOLI D, Ortelli P, Zivi I, Cian V, et al
    Efficacy of intensive multidisciplinary rehabilitation in Parkinson's disease: a randomised controlled study.
    J Neurol Neurosurg Psychiatry. 2018 Jan 10. pii: jnnp-2017-316437.
    PubMed     Text format     Abstract available


    December 2017
  10. RODRIGUEZ-ROJAS R, Carballo-Barreda M, Alvarez L, Guridi J, et al
    Subthalamotomy for Parkinson's disease: clinical outcome and topography of lesions.
    J Neurol Neurosurg Psychiatry. 2017 Dec 8. pii: jnnp-2017-316241.
    PubMed     Text format     Abstract available


    November 2017
  11. BARBOSA PM, Grippe T, Lees AJ, O'Sullivan S, et al
    Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa.
    J Neurol Neurosurg Psychiatry. 2017 Nov 24. pii: jnnp-2017-317298.
    PubMed     Text format    


    October 2017
  12. RICCIARDI L, Lambert C, Micco R, Morgante F, et al
    Can we predict development of impulsive-compulsive behaviours in Parkinson's disease?
    J Neurol Neurosurg Psychiatry. 2017 Oct 27. pii: jnnp-2017-317007.
    PubMed     Text format     Abstract available


  13. FANTINI ML, Figorilli M, Arnulf I, Zibetti M, et al
    Sleep and REM sleep behaviour disorder in Parkinson's disease with impulse control disorder.
    J Neurol Neurosurg Psychiatry. 2017 Oct 24. pii: jnnp-2017-316576.
    PubMed     Text format     Abstract available


  14. WARREN N, O'Gorman C, Lehn A, Siskind D, et al
    Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases.
    J Neurol Neurosurg Psychiatry. 2017 Oct 10. pii: jnnp-2017-315985.
    PubMed     Text format     Abstract available


  15. SIMUNI T, Caspell-Garcia C, Coffey CS, Weintraub D, et al
    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.
    J Neurol Neurosurg Psychiatry. 2017 Oct 6. pii: jnnp-2017-316213.
    PubMed     Text format     Abstract available


    September 2017
  16. YE BS, Jeon S, Yoon S, Kang SW, et al
    Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Sep 26. pii: jnnp-2017-316075.
    PubMed     Text format     Abstract available


  17. CHUNG SJ, Yoo HS, Moon H, Oh JS, et al
    Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
    J Neurol Neurosurg Psychiatry. 2017 Sep 14. pii: jnnp-2017-315873.
    PubMed     Text format     Abstract available


  18. JOLING M, van den Heuvel OA, Berendse HW, Booij J, et al
    Serotonin transporter binding and anxiety symptoms in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Sep 12. pii: jnnp-2017-316193.
    PubMed     Text format     Abstract available


  19. THOMPSON JA, Tekriwal A, Felsen G, Ozturk M, et al
    Sleep patterns in Parkinson's disease: direct recordings from the subthalamic nucleus.
    J Neurol Neurosurg Psychiatry. 2017 Sep 2. pii: jnnp-2017-316115.
    PubMed     Text format     Abstract available


    August 2017
  20. SUZUKI K, Okuma Y, Uchiyama T, Miyamoto M, et al
    Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.
    J Neurol Neurosurg Psychiatry. 2017 Aug 28. pii: jnnp-2017-316136.
    PubMed     Text format     Abstract available


  21. ROSSI PJ, Shute JB, Opri E, Molina R, et al
    Impulsivity in Parkinson's disease is associated with altered subthalamic but not globus pallidus internus activity.
    J Neurol Neurosurg Psychiatry. 2017 Aug 19. pii: jnnp-2016-315325.
    PubMed     Text format     Abstract available


    July 2017
  22. CILIA R, Asselta R, Cereda E, Benfante R, et al
    Opioid K receptor variant is associated with a delayed onset of dyskinesias in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jul 19. pii: jnnp-2017-316235.
    PubMed     Text format    


    June 2017
  23. VAN DER KOLK NM, de Vries NM, Penko AL, van der Vlugt M, et al
    A remotely supervised home-based aerobic exercise programme is feasible for patients with Parkinson's disease: results of a small randomised feasibility trial.
    J Neurol Neurosurg Psychiatry. 2017 Jun 12. pii: jnnp-2017-315728.
    PubMed     Text format    


  24. AARSLAND D, Rajkumar AP, Hye A
    Novel evidence associates higher plasma alpha-synuclein levels and cognitive impairment in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jun 12. pii: jnnp-2017-315821.
    PubMed     Text format    


  25. NISHIO Y, Yokoi K, Uchiyama M, Mamiya Y, et al
    Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Jun 9. pii: jnnp-2017-315741.
    PubMed     Text format     Abstract available


    May 2017
  26. AMARA AW, Chahine LM, Caspell-Garcia C, Long JD, et al
    Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 May 29. pii: jnnp-2016-315023.
    PubMed     Text format     Abstract available


  27. LIN CH, Yang SY, Horng HE, Yang CC, et al
    Plasma alpha-synuclein predicts cognitive decline in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 May 26. pii: jnnp-2016-314857.
    PubMed     Text format     Abstract available


    April 2017
  28. FFYTCHE DH, Pereira JB, Ballard C, Chaudhuri KR, et al
    Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.
    J Neurol Neurosurg Psychiatry. 2017;88:325-331.
    PubMed     Text format     Abstract available


  29. ANTONINI A, Barone P, Bonuccelli U, Annoni K, et al
    ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017;88:317-324.
    PubMed     Text format     Abstract available


  30. FIRBANK MJ, Yarnall AJ, Lawson RA, Duncan GW, et al
    Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.
    J Neurol Neurosurg Psychiatry. 2017;88:310-316.
    PubMed     Text format     Abstract available


    March 2017
  31. LAWSON RA, Yarnall AJ, Duncan GW, Breen DP, et al
    Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017 Mar 1. pii: jnnp-2016-315099.
    PubMed     Text format     Abstract available


  32. HO AL, Ali R, Connolly ID, Henderson JM, et al
    Awake versus asleep deep brain stimulation for Parkinson's disease: a critical comparison and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2017 Mar 1. pii: jnnp-2016-314500.
    PubMed     Text format     Abstract available


  33. NOYCE AJ, Schrag A, Masters JM, Bestwick JP, et al
    Subtle motor disturbances in PREDICT-PD participants.
    J Neurol Neurosurg Psychiatry. 2017;88:212-217.
    PubMed     Text format     Abstract available


    December 2016
  34. TEKRIWAL A, Kern DS, Tsai J, Ince NF, et al
    REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Dec 13. pii: jnnp-2016-314471.
    PubMed     Text format     Abstract available


    November 2016
  35. FERRARI R, Wang Y, Vandrovcova J, Guelfi S, et al
    Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
    J Neurol Neurosurg Psychiatry. 2016 Nov 29. pii: jnnp-2016-314411.
    PubMed     Text format     Abstract available


  36. COLLETT J, Franssen M, Meaney A, Wade D, et al
    Phase II randomised controlled trial of a 6-month self-managed community exercise programme for people with Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Nov 11. pii: jnnp-2016-314508.
    PubMed     Text format     Abstract available


    October 2016
  37. DE PABLO-FERNANDEZ E, Breen DP, Bouloux PM, Barker RA, et al
    Neuroendocrine abnormalities in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Oct 31. pii: jnnp-2016-314601.
    PubMed     Text format     Abstract available


    September 2016
  38. SWALLOW DM, Lawton MA, Grosset KA, Malek N, et al
    Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.
    J Neurol Neurosurg Psychiatry. 2016 Sep 26. pii: jnnp-2016-313642.
    PubMed     Text format     Abstract available


    August 2016
  39. LITTLE S, Tripoliti E, Beudel M, Pogosyan A, et al
    Adaptive deep brain stimulation for Parkinson's disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting.
    J Neurol Neurosurg Psychiatry. 2016 Aug 16. pii: jnnp-2016-313518.
    PubMed     Text format    


    July 2016
  40. KALBE E, Rehberg SP, Heber I, Kronenbuerger M, et al
    Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    J Neurol Neurosurg Psychiatry. 2016 Jul 8. pii: jnnp-2016-313838.
    PubMed     Text format     Abstract available


    June 2016
  41. MCMILLAN CT, Wolk DA
    Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Jun 9. pii: jnnp-2015-312690.
    PubMed     Text format     Abstract available


    April 2016
  42. KRAEMMER J, Smith K, Weintraub D, Guillemot V, et al
    Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Apr 13. pii: jnnp-2015-312848.
    PubMed     Text format     Abstract available


    March 2016
  43. ERRO R, Schneider SA, Stamelou M, Quinn NP, et al
    What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.
    J Neurol Neurosurg Psychiatry. 2016;87:319-23.
    PubMed     Text format     Abstract available


    February 2016
  44. XIAO B, Ng HH, Takahashi R, Tan EK, et al
    Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges.
    J Neurol Neurosurg Psychiatry. 2016 Feb 1. pii: jnnp-2015-312036.
    PubMed     Text format     Abstract available


    January 2016
  45. EVANS JR, Cummins G, Breen DP, Foltynie T, et al
    Comparative epidemiology of incident Parkinson's disease in Cambridgeshire, UK.
    J Neurol Neurosurg Psychiatry. 2016 Jan 22. pii: jnnp-2015-312581.
    PubMed     Text format    


  46. NOYCE AJ, Lees AJ, Schrag AE
    The prediagnostic phase of Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2016 Jan 11. pii: jnnp-2015-311890.
    PubMed     Text format     Abstract available


    December 2015
  47. MOISAN F, Kab S, Mohamed F, Canonico M, et al
    Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2015 Dec 23. pii: jnnp-2015-312283.
    PubMed     Text format     Abstract available


    November 2015
  48. SMITH KM, Xie SX, Weintraub D
    Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.
    J Neurol Neurosurg Psychiatry. 2015 Nov 3. pii: jnnp-2015-311827.
    PubMed     Text format     Abstract available


    September 2015
  49. LITTLE S, Beudel M, Zrinzo L, Foltynie T, et al
    Bilateral adaptive deep brain stimulation is effective in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2015 Sep 30. pii: jnnp-2015-310972.
    PubMed     Text format     Abstract available


  50. YAMADA K, Shinojima N, Hamasaki T, Kuratsu JI, et al
    Subthalamic nucleus stimulation improves Parkinson's disease-associated camptocormia in parallel to its preoperative levodopa responsiveness.
    J Neurol Neurosurg Psychiatry. 2015 Sep 30. pii: jnnp-2015-310926.
    PubMed     Text format     Abstract available


  51. TADA S, Furuta M, Fukada K, Hirozawa D, et al
    Severe parkinsonism associated with anti-CRMP5 antibody-positive paraneoplastic neurological syndrome and abnormal signal intensity in the bilateral basal ganglia.
    J Neurol Neurosurg Psychiatry. 2015 Sep 15. pii: jnnp-2015-311569.
    PubMed     Text format    


  52. SAMMARTINO F, Krishna V, King NK, Bruno V, et al
    Sequence of electrode implantation and outcome of deep brain stimulation for Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2015 Sep 9. pii: jnnp-2015-311426.
    PubMed     Text format     Abstract available


  53. ADAMS-CARR KL, Bestwick JP, Shribman S, Lees A, et al
    Constipation preceding Parkinson's disease: a systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2015 Sep 7. pii: jnnp-2015-311680.
    PubMed     Text format     Abstract available


    August 2015
  54. DE CHAZERON I, Pereira B, Chereau-Boudet I, Durif F, et al
    Impact of localisation of deep brain stimulation electrodes on motor and neurobehavioural outcomes in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2015 Aug 21. pii: jnnp-2015-310953.
    PubMed     Text format     Abstract available


  55. FONG M, Ghahreman A, Masters L, Huynh W, et al
    Large intracranial meningioma masquerading as Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2015 Aug 4. pii: jnnp-2015-311531.
    PubMed     Text format    


    July 2015
  56. LING H, Kearney S, Yip HL, Silveira-Moriyama L, et al
    Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?
    J Neurol Neurosurg Psychiatry. 2015 Jul 24. pii: jnnp-2015-310756.
    PubMed     Text format     Abstract available


    June 2015
  57. FARRET MS, Cersosimo MG, Ramirez Gomez CC, Micheli F, et al
    Clinicoradiological comparisons between vascular parkinsonism and Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2015 Jun 10. pii: jnnp-2015-311155.
    PubMed     Text format    


    May 2015
  58. WATANABE H, Sobue G
    Filling in the missing puzzle piece between cardiac MIBG scintigraphy findings and Parkinson's disease pathology.
    J Neurol Neurosurg Psychiatry. 2015 May 22. pii: jnnp-2015-310862.
    PubMed     Text format    


  59. MUXI A
    The 'parkinsonian heart': a diagnostic and prognostic tool.
    J Neurol Neurosurg Psychiatry. 2015 May 18. pii: jnnp-2015-310785.
    PubMed     Text format    


  60. VRIEND C, Boedhoe PS, Rutten S, Berendse HW, et al
    A smaller amygdala is associated with anxiety in Parkinson's disease: a combined FreeSurfer-VBM study.
    J Neurol Neurosurg Psychiatry. 2015 May 18. pii: jnnp-2015-310383.
    PubMed     Text format     Abstract available


    April 2015
  61. SATZER D, Maurer EW, Lanctin D, Guan W, et al
    Anatomic correlates of deep brain stimulation electrode impedance.
    J Neurol Neurosurg Psychiatry. 2015;86:398-403.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: